UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 350

Sortiert nach

Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment

Current oncology reports, 2022-05, Vol.24 (5), p.633-644

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2223-2229

2011

Link zum Volltext

Verfügbarkeit prüfen

Burden of Sickle Cell Disease in Ghana: The Korle-Bu Experience

Advances in hematology, 2018, Vol.2018, p.1-5

2018

Link zum Volltext

Verfügbarkeit prüfen

IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch

Advances in hematology, 2021, Vol.2021, p.1-12

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and management of non-gastrointestinal non-ocular extranodal mucosa associated lymphoid tissue (ENMALT) marginal zone lymphomas

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.99-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma

Advances in hematology, 2022-02, Vol.2022, p.1-7

2022

Link zum Volltext

Verfügbarkeit prüfen

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification

Blood, 2011-03, Vol.117 (11), p.3163-3171

2011

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Advances in hematology, 2022-01, Vol.2022, p.1-8

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study

Advances in hematology, 2022-01, Vol.2022, p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of hairy cell leukemia variant with obinutuzumab

Annals of hematology, 2022-03, Vol.101 (3), p.703-704

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the Levels of Knowledge, Attitude, and Practice Associated with Sickle Cell Disease and Premarital Genetic Counseling in 350 Saudi Adults

Advances in hematology, 2019, Vol.2019, p.1-7

2019

Link zum Volltext

Verfügbarkeit prüfen

Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia

Advances in hematology, 2019, Vol.2019, p.1-6

2019

Link zum Volltext

Verfügbarkeit prüfen

Magnitude of Anemia and Associated Factors among HIV-Infected Children Receiving Antiretroviral Therapy in Pastoral Community, Ethiopia: A Retrospective Cross-Sectional Study

Advances in hematology, 2020-09, Vol.2020, p.1-8

2020

Link zum Volltext

Verfügbarkeit prüfen

Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4524-4532

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Haematologica (Roma), 2010-10, Vol.95 (10), p.1705

2010

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?

Expert review of hematology, 2021-04, Vol.14 (4), p.355-363

Matutes, Estella

2021

Link zum Volltext

Verfügbarkeit prüfen

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

British journal of haematology, 2012-11, Vol.159 (3), p.322-328

2012

Link zum Volltext

Verfügbarkeit prüfen

Lung Function Abnormalities in Sickle Cell Anaemia

Advances in hematology, 2019, Vol.2019, p.1-8

2019

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D and Nonskeletal Complications among Egyptian Sickle Cell Disease Patients

Advances in hematology, 2018, Vol.2018, p.1-7

2018

Link zum Volltext

Verfügbarkeit prüfen

Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma

EJHaem, 2023-05, Vol.4 (2), p.522-523

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?

Haematologica (Roma), 2020-09, Vol.105 (9), p.e484-e484

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(299)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(214)
Science & Technology
(214)
Humans
(206)
Hematology
(175)
Male
(120)
Female
(109)
Aged
(96)
Middle Aged
(96)
Biological And Medical Sciences
(95)
Medical Sciences
(93)
Adult
(86)
Oncology
(86)
Hematologic And Hematopoietic Diseases
(82)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(79)
Immunophenotyping
(45)
Prognosis
(41)
Aged, 80 And Over
(40)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(34)
Mutation
(27)
Treatment Outcome
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(79)
British Journal Of Haematology
(49)
Leukemia & Lymphoma
(43)
Haematologica
(23)
Advances In Hematology
(19)
Leukemia Research
(10)
Cancer
(8)
Case Reports In Medicine
(8)
Best Practice & Research. Clinical Haematology
(6)
Leukemia
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment

Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

Burden of Sickle Cell Disease in Ghana: The Korle-Bu Experience

IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Clinical features and management of non-gastrointestinal non-ocular extranodal mucosa associated lymphoid tissue (ENMALT) marginal zone lymphomas

Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study

Successful treatment of hairy cell leukemia variant with obinutuzumab

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

Quantifying the Levels of Knowledge, Attitude, and Practice Associated with Sickle Cell Disease and Premarital Genetic Counseling in 350 Saudi Adults

Double-Blind Clinical Trial of Arginine Supplementation in the Treatment of Adult Patients with Sickle Cell Anaemia

Magnitude of Anemia and Associated Factors among HIV-Infected Children Receiving Antiretroviral Therapy in Pastoral Community, Ethiopia: A Retrospective Cross-Sectional Study

Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?

Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma

Lung Function Abnormalities in Sickle Cell Anaemia

Vitamin D and Nonskeletal Complications among Egyptian Sickle Cell Disease Patients

Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma

Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?

Suchergebnisse filtern